The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy
Open Forum Infect Dis. 2020 Nov 26;7(12):ofaa569. doi: 10.1093/ofid/ofaa569.eCollection 2020 Dec.
Alicia B Carver1, Autumn D Zuckerman1, Joshua DeClercq2, Leena Choi2, Cody A Chastain3
Author information
1Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
2Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
3Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Free PMC article
Abstract
Rates of persistent viremia (PV) while on direct-acting antiviral therapy were low (5.7%) in a real-world cohort of 983 patients. High sustained virologic response rates were achieved both in patients with PV (92.9%) and those with rapid virologic response (96.5%), without significant differences.